442
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association of Toll-like Receptors 1, 2, 4, 6, 8, 9 and 10 Genes Polymorphisms and Susceptibility to Pulmonary Tuberculosis in Sudanese Patients

Pages 47-75 | Received 15 Jan 2023, Accepted 29 Mar 2023, Published online: 06 Apr 2023

References

  • Chun X, Peijun T, Cheng D, et al. Vitamin D receptor geneFOKI polymorphism contributes to increasing the risk of HIV-negative tuberculosis: evidence from a meta-analysis. PLoS One. 2015;10:e0140634. doi:10.1371/journal.pone.0140634
  • World Health Organization. Global Tuberculosis Report 2020. Geneva, Switzerland: World Health Organization; 2020.
  • World Health Organization. Coronavirus disease 2019 (COVID-19) situation report – 197; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200804-covid-19-sitrep-197.pdf?sfvrsn=94f7a01d_2. Accessed 5, August, 2020.
  • Faqihi F, Alharthy A, Noor AlFateh BA, Balahmar A, Karakitsos D. COVID-19 in a patient with active tuberculosis: a rare case-report. Respir Med Case Rep. 2020;31:101146.
  • Liu Y, Bi L, Chen Y, Wang Y, Fleming J, Yu Y. Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity. MedRxiv BioRxiv. 2020. doi:10.1101/2020.03.10.20033795
  • Swaminathan S, Nagendran G. HIV and tuberculosis in India. J Biosci. 2008;33(4):527–537.
  • World Health Organization. TB/HIV FACTS 2009; 2009. Available from: https://www.who.int/tb/challenges/hiv/factsheet_hivtb_2009update.pdf. Accessed 7 May, 2020.
  • Dirlikov E, Raviglione M, Scano F. Global tuberculosis control: toward the 2015 targets and beyond. Ann Intern Med. 2015;163(1):52–58.
  • Diedrich CR, Flynn JL. HIV-1/mycobacterium tuberculosis co-infection immunology: how does HIV-1 exacerbate tuberculosis? Infect Immun. 2011;79(4):1407–1417.
  • Jiang H, Zhou Y, Tang W. Maintaining HIV care during the COVID-19 pandemic. The lancet. 2020;3018(20):30105.
  • Fernando SL, Britton WJ. Genetic susceptibility to mycobacterial disease in humans. Immunol Cell Biol. 2006;84(2):125–137. doi:10.1111/j.1440-1711.2006.01420.x
  • Karlsson EK, Kwiatkowski DP, Sabeti PC. Natural selection and infectious disease in human populations. Nat Rev Genet. 2014;15(6):379–393.
  • Casanova JL, Abel L.Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol. 2002;20:581–620.
  • Guide SV, Holland SM. Host susceptibility factors in mycobacterial infection: genetics and body morphotype. Infect Dis Clin North Am. 2002;16:163–186.
  • Bellamy R, NuldaBeyers KP, McAdam WJ, et al. Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc Natl Acad Sci U S A. 2000;97:8005–8009.
  • Graham S, Cooke Sarah J, Keith P, et al. Mapping of a novel susceptibility locus suggests a role for MC3R and CTSZ in human tuberculosis. Am J Respir Crit Care Med. 2008;178:203–207.
  • Moller M, Hoal EG. Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis. Tuberculosis. 2010;90:71–83.
  • Mahasirimongkol S, Yanai H, Nishida N, et al. Genome-wide SNP-based linkage analysis of tuberculosis in Thais. Genes Immun. 2009;10:77–83.
  • Miller EN, Jamieson SE, Joberty C, et al. Genome-wide scans for leprosy and tuberculosis susceptibility genes in Brazilians. Genes Immun. 2004;5:63–67.
  • Mahasirimongkol S, Yanai H, Mushiroda T, et al. Genome-wide association studies of tuberculosis in Asians identify distinct at-risk locus for young tuberculosis. J Hum Genet. 2012;57:363–367.
  • Thye T, Vannberg FO, Wong SH, et al. Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2. Nat Genet. 2010;42:739–741.
  • Bafica A, Scanga CA, Feng CG, Leifer C, Cheever A, Sher A. TLR9 Regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Exp Med. 2005;202:1715–1724.
  • Carvalho NB, Oliveira FS, Duraes FV, et al. Toll-like receptor 9 is required for full host resistance to Mycobacterium avium infection but plays no role in induction of Th1 responses. Infect Immun. 2011;79:1638–1646.
  • Chen YC, Hsiao CC, Chen CJ, et al. Toll-like receptor 2 gene polymorphisms, pulmonary tuberculosis, and natural killer cell counts. BMC Med Genet. 2010;11:17.
  • Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem. 1999;274:10689–10692.
  • Azad AK, Sadee W, Schlesinger LS. Innate immune gene polymorphisms in tuberculosis. Infect Immun. 2012;80:3343–3359.
  • Kobayashi K, Yuliwulandari R, Yanai H, et al. Association of TLR polymorphisms with development of tuberculosis in Indonesian females. Tissue Antigens. 2012;79:190–197.
  • Najmi N, Kaur G, Sharma SK, Mehra NK. Human toll-like receptor 4 polymorphisms TLR4 Asp299Gly and Thr399Ile influence susceptibility and severity of pulmonary tuberculosis in the Asian Indian population. Tissue Antigens. 2010;76:102–109.
  • Thada S, Valluri V, Gaddam SL. Influence of toll like receptor gene polymorphisms to tuberculosis susceptibility in humans. Scand J Immunol. 2013;78:221–229.
  • Velez DR, Wejse C, Stryjewski ME, et al. Variants in toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans. Hum Genet. 2010;127:65–73.
  • Zaki HY, Leung KH, Yiu WC, Gasmelseed N, Elwali NE, Yip SP. Common polymorphisms in TLR4 gene associated with susceptibility to pulmonary tuberculosis in the Sudanese. Int J Tuberc Lung Dis. 2012;16:934–940.
  • Zhang Y, Jiang T, Yang X, et al. Toll-like receptor −1, −2, and −6 polymorphisms and pulmonary tuberculosis susceptibility: a systematic review and meta-analysis. PLoS One. 2013;8:e63357.
  • Ocejo-Vinyals JG. Human toll-like receptor 1 T1805G polymorphism and susceptibility to pulmonary tuberculosis in northern Spain. Int J Tuberc Lung Dis. 2013;17:652–654.
  • Tian T, Jin S, Dong J, Li G. Lack of association between toll-like receptor 4 gene Asp299Gly and Thr399Ile polymorphisms and tuberculosis susceptibility: a meta-analysis. Infect Genet Evol. 2013;14:156–160.
  • Rosas-Taraco AG, Revol A, Salinas-Carmona MC, Rendon A, Caballero-Olin G, Arce-Mendoza AY. CD14 C(−159)T polymorphism is a risk factor for development of pulmonary tuberculosis. J Infect Dis. 2007;196:1698–1706.
  • Biswas D, Gupta SK, Sindhwani G, Patras A. TLR2 Polymorphisms, Arg753Gln and Arg677Trp, are not associated with increased burden of tuberculosis in Indian patients. BMC Res Notes. 2009;2:162.
  • Sanchez D, Lefebvre C, Rioux J, Garcia LF, Barrera LF. Evaluation of toll-like receptor and adaptor molecule polymorphisms for susceptibility to tuberculosis in a Colombian population. Int J Immunogenet. 2012;39:216–223.
  • Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783–801.
  • Ma X, Liu Y, Gowen BB, Graviss EA, Clark AG, Musser JM. Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease. PLoS One. 2007;2:e1318.
  • Ogus AC, Yoldas B, Ozdemir T, et al. The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur Clin Respir J. 2004;23:219.
  • Abel B, Thieblemont N, Quesniaux VJF, et al. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immun. 2002;169(6))::3155–3162.
  • Dalgic N. Arg753Gln polymorphism of the human Toll-like receptor 2 gene from infection to disease in pediatric tuberculosis. Hum Immunol. 2011;72:440.
  • Ben-Ali M, Barbouche MR, Bousnina S, Chabbou A, Dellagi K. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin Diagn Lab Immunol. 2004;11:625.
  • Thuong NT, Hawn TR, Thwaites GE, et al. A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis. Genes Immun. 2007;8:422.
  • Etokebe GE, Skjeldal F, Nilsen N, et al. Toll-like receptor 2 (P631H) mutant impairs membrane internalization and is a dominant negative allele. Scand J Immunol. 2010;71:369.
  • Ferwerda B. The toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania. AIDS. 2007;21:1375.
  • Davila S, Hibberd ML, Hari Dass R, et al. Genetic association and expression studies indicate a role of toll-like receptor 8 in pulmonary tuberculosis. PLoS Genet. 2008;4:e1000218.
  • Quesniaux V, Fremond C, Jacobs M, et al. Toll-like receptor pathways in the immune responses to mycobacteria. Microbes Infect. 2004;6:946.
  • Jo EK, Yang CS, Choi CH, Harding CV. Intracellular signalling cascades regulating innate immune responses to Mycobacteria: branching out from Toll-like receptors. Cell Microbiol. 2007;9:1087.
  • Sinha E, Biswas SK, Mittal M, et al. Toll-like Receptor 1 743 A>G, 1805 T>G & Toll-like Receptor 6 745 C>T gene polymorphism and tuberculosis: a case control study of north Indian population from Agra (India). Hum Immunol. 2014;75:880–886. PMID: 24984237.
  • Dittrich N, Berrocal-Almanza LC, Thada S, et al. Toll-like receptor 1 variations influence susceptibility and immune response to Mycobacterium tuberculosis. Tuberculosis. 2015;95:328–335.
  • Salie M, Daya M, Lucas LA, et al. Association of Toll-like receptors with susceptibility to tuberculosis suggests sex-specific effects of TLR8 polymorphisms. Infect Genet Evol. 2015;34:221–229.
  • Wu L, Hu Y, Li D, Jiang W, Xu B. Screening toll-like receptor markers to predict latent tuberculosis infection and subsequent tuberculosis disease in a Chinese population. BMC Med Genet. 2015;16:19. PMID: 25928077. doi:10.1186/s12881-015-0166-1
  • Folwaczny M, Glas J, Torok HP, Limbersky O, Folwaczny C. Toll-like receptor (TLR) 2 and 4 mutations in periodontal disease. Clin Exp Immunol. 2004;135(2):330–335.
  • Rizvi I, Garg RK, Jain A, et al. Vitamin D status, Vitamin D receptor and Toll like receptor-2 polymorphisms in tuberculous meningitis: a case-control study. Infection. 2016;44:633–640.
  • Zhao Y, Bu H, Hong K, et al. Genetic polymorphisms of CCL1 rs2072069 G/A and TLR2 rs3804099 T/C in pulmonary or meningeal tuberculosis patients. Int J Clin Exp Pathol. 2015;8:12608–12620.
  • Pulido I, Leal M, Genebat M, Pacheco YM. The TLR4 ASP299GLY polymorphism is a risk factor for active tuberculosis in caucasian HIV-infected patients. Curr HIV Res. 2010;8(3):253–258.
  • Selvaraj P. Toll-like receptor and TIRAP gene polymorphisms in pulmonary tuberculosis patients of South India. Tuberculosis. 2010;90:306.
  • Newport MJ, Allen A, Awomoyi AA, et al. The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia. Tuberculosis. 2004;84:347.
  • Xue Y. Toll-like receptors 2 and 4 gene polymorphisms in a southeastern Chinese population with tuberculosis. International. J Immunogenet. 2010;37:135.
  • Shey MS, Randhawa AK, Bowmaker M, et al. Single nucleotide polymorphisms in toll-like receptor 6 are associated with altered lipopeptide- and mycobacteria-induced interleukin–6 secretion. Genes Immun. 2010;11:561–572. PMID: 20445564. doi:10.1038/gene.2010.14
  • Randhawa AK, Shey MS, Keyser A, et al. Association of human TLR1 and TLR6 deficiency with altered immune responses to BCG vaccination in South African Infants. PLoS Pathog. 2011;7. doi:10.1371/journal.ppat.1002174
  • Dalgic N, Tekin D, Kayaalti Z, Cakir E, Soylemezoglu T, Sancar M. Relationship between toll-like receptor 8 gene polymorphisms and pediatric pulmonary tuberculosis. Dis Markers. 2011;31(1):33–38.
  • Bukhari M, Aslam MA, Khan A, et al. TLR8 gene polymorphism and association in bacterial load in southern Punjab of Pakistan: an association study with pulmonary tuberculosis. Int J Immunogenet. 2015;42(1):46–51.
  • Chimusa ER, Zaitlen N, Daya M, et al. Genome-wide association study of ancestry-specific TB risk in the South African Coloured population. Hum Mol Genet. 2014;23(3):796–809.
  • Cheng PL, Eng HL, Chou MH, You HL, Lin TM. Genetic polymorphisms of viral infection-associated Toll-like receptors in Chinese population. Transl Res. 2007;150::311–318.
  • Nilsson D, Andiappan AK, Hallden C, et al. Toll-like receptor gene polymorphisms are associated with allergic rhinitis: a case control study. BMC Med Genet. 2012;13:66.
  • Chen Z, Wang W, Liang J, Wang J, Feng S, Zhang G. Association between toll-like receptors 9 (TLR9) gene polymorphism and risk of pulmonary tuberculosis: meta-analysis. BMC Pulm Med. 2015;15(1):1.
  • Bharti D, Kumar A, Mahla RS, et al. The role of TLR9 polymorphism in susceptibility to pulmonary tuberculosis. Immunogenetics. 2014;66(12):675–681.
  • Hamann L, Glaeser C, Hamprecht A, Gross M, Gomma A, Schumann RR. Toll like receptor (TLR)-9 promotor polymorphisms and at herosclerosis. Clin Chim Acta. 2006;364(1–2):303–307.
  • Roszak A, Lianeri M, Sowinska A, Jagodzinski PP. Involvement of Toll-like Receptor 9 polymorphism in cervical cancer development. Mol Biol Rep. 2012;39(8):8425–8430.
  • Ng MT, Van’t Hof R, Crockett JC, et al. Increase in NF-kappaB binding affinity of the variant C allele of the toll-like receptor 9–1237 T/C polymorphism is associated with Helicobacter pylori-induced gastric disease. Infect Immun. 2010;78(3):1345–1352.
  • Fischer J, Weber ANR, Bohm S, et al. Sex-specific effects of TLR9 promoter variants on spontaneous clearance of HCV infection. Gut. 2017;66(10):1829–1837.
  • Torres-García D, Cruz-Lagunas A, García-Sancho Figueroa MC, et al. Variants in toll-like receptor 9 gene influence susceptibility to tuberculosis in a Mexican population. J Transl Med. 2013;11:220.
  • Graustein AD, Horne DJ, Arentz M, et al. TLR9 gene region polymorphisms and susceptibility to tuberculosis in Vietnam. Tuberculosis. 2015;95:190–196.
  • Sanders MS, van Well GT, Ouburg S, Lundberg PS, van Furth AM, Morré SA. Single nucleotide polymorphisms in TLR9 are highly associated with susceptibility to bacterial meningitis in children. Clin Infect Dis. 2011b;52:475–480.
  • Wujcicka W, Gaj Z, Wilczy_nski J, Nowakowska D. Possible role of TLR4 and TLR9 SNPs in protection against congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis. 2015;4:2121–2129.
  • Bulat-Kardum LJ, Etokebe GE, Lederer P, Balen S, Dembic Z. Genetic polymorphisms in the toll-like receptor 10, interleukin (IL)17A and IL17F genes differently affect the risk for tuberculosis in Croatian population. Scand J Immunol. 2015;82(1):63–69. doi:10.1111/sji.12300
  • Tang F, Li Z, Wang Y, et al. Toll-like receptor 1 and 10 polymorphisms, Helicobacter pylori susceptibility and risk of gastric lesions in a high-risk Chinese population. Infect Genet Evol. 2015;31:263–269. doi:10.1016/j.meegid.2015.02.005